Targeted cancer. These "smart weapons" hit cancer in novel ways

Jeanne Held-Warmkessel1

  • 1Fox Chase Cancer Center in Philadelphia, PA, USA.

Nursing
|August 23, 2008
PubMed

Insights

Innovative cancer therapies introduce novel adverse reactions. Healthcare providers must be ready to identify and manage these new side effects for optimal patient care.

Area of Science:

  • Oncology
  • Pharmacology
  • Clinical Medicine

Background:

  • Novel cancer therapies, including immunotherapies and targeted agents, are rapidly evolving.
  • These advanced treatments offer improved efficacy but can present unique toxicity profiles.
  • Understanding potential adverse events is crucial for patient safety and treatment success.

Observation:

  • Emerging adverse reactions associated with innovative cancer treatments require clinical vigilance.
  • These reactions may differ significantly from those seen with traditional chemotherapy.
  • Early recognition and prompt management are key to mitigating patient harm.

Findings:

  • A spectrum of new adverse reactions has been identified in patients receiving cutting-edge cancer therapies.
  • Specific examples include immune-related adverse events (irAEs) and unique organ toxicities.
  • Management strategies are being developed to address these novel toxicities.

Implications:

  • Oncologists and healthcare teams need updated knowledge to manage these emerging adverse events.
  • Clinical guidelines and educational resources are essential for preparedness.
  • Effective management of novel toxicities will enhance the tolerability and success of modern cancer treatments.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...